AIM: To investigate patient experiences with pharmacogenetic (PGx) testing. METHODS: Patients were offered PGx testing through a study on pharmacist-assisted delivery of PGx testing and invited to complete pre- and post-testing surveys about their experience. RESULTS: Of 63 patients tested, 17 completed the baseline survey (27%). Interest in testing was mostly impacted by desire to inform selection of best treatment (n = 13). Seven of 12 patients that completed the follow-up survey indicated that their provider discussed the test result with them. Five patients understood their test result very or somewhat well. All would be likely to have PGx testing again. CONCLUSION: Patients perceived PGx testing to be useful, though more effort may be needed to improve patient-provider communication of test results.
AIM: To investigate patient experiences with pharmacogenetic (PGx) testing. METHODS:Patients were offered PGx testing through a study on pharmacist-assisted delivery of PGx testing and invited to complete pre- and post-testing surveys about their experience. RESULTS: Of 63 patients tested, 17 completed the baseline survey (27%). Interest in testing was mostly impacted by desire to inform selection of best treatment (n = 13). Seven of 12 patients that completed the follow-up survey indicated that their provider discussed the test result with them. Five patients understood their test result very or somewhat well. All would be likely to have PGx testing again. CONCLUSION:Patients perceived PGx testing to be useful, though more effort may be needed to improve patient-provider communication of test results.
Authors: Elena M Stoffel; Beth Ford; Rowena C Mercado; Darashana Punglia; Wendy Kohlmann; Peggy Conrad; Amie Blanco; Kristen M Shannon; Mark Powell; Stephen B Gruber; Jonathan Terdiman; Daniel C Chung; Sapna Syngal Journal: Clin Gastroenterol Hepatol Date: 2008-02-07 Impact factor: 11.382
Authors: P Madadi; Y Joly; D Avard; D C Chitayat; M A Smith; C J D Ross; B C Carleton; M R Hayden; G Koren Journal: Clin Pharmacol Ther Date: 2010-08-25 Impact factor: 6.875
Authors: David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman Journal: Health Psychol Date: 2002-11 Impact factor: 4.267
Authors: S L Charland; B C Agatep; V Herrera; B Schrader; F W Frueh; M Ryvkin; J Shabbeer; J J Devlin; H R Superko; E J Stanek Journal: Pharmacogenomics J Date: 2013-08-27 Impact factor: 3.550
Authors: Matthew B Lanktree; Gwyneth Zai; Laura E Vanderbeek; Daniel E Giuffra; David S Smithson; Lucas B Kipp; Timothy R Dalseg; Mark Speechley; James L Kennedy Journal: Hum Psychopharmacol Date: 2014-03-07 Impact factor: 1.672
Authors: Jason L Vassy; Sojeong Chun; Sanjay Advani; Sophie A Ludin; Jason G Smith; Elaine C Alligood Journal: Clin Pharmacol Ther Date: 2018-10-18 Impact factor: 6.875
Authors: Melanie F Myers; Xue Zhang; Brooke McLaughlin; Diane Kissell; Cassandra L Perry; Matthew Veerkamp; Kejian Zhang; Ingrid A Holm; Cynthia A Prows Journal: Pharmacogenomics Date: 2017-07-26 Impact factor: 2.533
Authors: Kristin Wiisanen Weitzel; Benjamin Q Duong; Meghan J Arwood; Aniwaa Owusu-Obeng; Noura S Abul-Husn; Barbara A Bernhardt; Brian Decker; Joshua C Denny; Eric Dietrich; John Gums; Ebony B Madden; Toni I Pollin; Rebekah Ryanne Wu; Susanne B Haga; Carol R Horowitz Journal: Pharmacogenomics Date: 2019-10 Impact factor: 2.533
Authors: Ann M Moyer; Brian Dukek; Patti Duellman; Brittany Schneider; Laurie Wakefield; Jennifer M Skierka; Rajeswari Avula; Aditya V Bhagwate; Krishna R Kalari; Justin D Kreuter; Matthew P Goetz; Judy C Boughey; John L Black; Manish J Gandhi Journal: Hum Immunol Date: 2020-06-13 Impact factor: 2.850
Authors: Chandrama Mukherjee; Kevin M Sweet; Jasmine A Luzum; Mahmoud Abdel-Rasoul; Michael F Christman; Joseph P Kitzmiller Journal: Per Med Date: 2017-09-01 Impact factor: 2.512